QCM Cayman’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

QCM Cayman’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,162	Closed	-$40K	–	158
2021 Q3	$40K	Buy	+18,162	New	+$49.6K	0.11%	106

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QCM Cayman's SPPI Position: Q4 2021 in Review

QCM Cayman sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2021, closing a stake of 18,162 shares — an estimated $40K sold.

QCM Cayman first reported a position in SPPI in Q3 2021 and held it in 1 quarter. The position peaked at $40K in Q3 2021. 142 funds tracked by Wall St. Rank hold SPPI as of Q4 2021.

QCM Cayman reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
QCM Cayman sold 18,162 Spectrum Pharmaceuticals Inc shares in Q4 2021, an estimated $40K.
QCM Cayman first reported a position in Spectrum Pharmaceuticals Inc in Q3 2021 and held it in 1 quarter.
QCM Cayman's Spectrum Pharmaceuticals Inc position peaked at $40K in Q3 2021.
142 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2021.

Based on QCM Cayman's 13F filing for Q4 2021, filed 11 Feb 2022.